Filing Details

Accession Number:
0000937556-20-000061
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-04-07 16:21:37
Reporting Period:
2020-04-06
Accepted Time:
2020-04-07 16:21:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
937556 Masimo Corp MASI Electromedical & Electrotherapeutic Apparatus (3845) 330368882
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1734507 Bilal Muhsin C/O Masimo Corporation
52 Discovery
Irvine CA 92618
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-04-06 2,000 $21.69 2,000 No 4 M Direct
Common Stock Disposition 2020-04-06 2,000 $184.00 0 No 4 S Direct
Common Stock Acquisiton 2020-04-06 5,000 $34.51 5,000 No 4 M Direct
Common Stock Disposition 2020-04-06 5,000 $184.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (Right to Buy) Disposition 2020-04-06 2,000 $21.69 2,000 $21.69
Common Stock Non-Qualified Stock Option (Right to Buy) Disposition 2020-04-06 5,000 $34.51 5,000 $34.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-08-20 2024-08-20 No 4 M Direct
35,000 2016-05-13 2025-05-13 No 4 M Direct
Footnotes
  1. The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of March 5, 2020, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
  2. This option was granted on August 20, 2014 and is exercisable as the option vests. The option vested over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
  3. This option was granted on May 13, 2015 and is exercisable as the option vests. The option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.